BioLine RX Ltd ADR buy stratec
Start price
08.12.17
/
50%
€223.25
Target price
03.12.18
€608.85
Performance (%)
-36.36%
End price
03.12.18
€142.07
Summary
This prediction ended on 03.12.18 with a price of €142.07. Massive losses of -36.36% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
BioLine RX Ltd ADR | 16.794% | 16.794% | -47.603% | -71.875% |
iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
Comments by stratec for this prediction
In the thread BioLine RX Ltd ADR diskutieren
stratec stimmt der Buy-Einschätzung von tamam zu
stratec stimmt am 08.12.2017 der Buy-Einschätzung von tamam mit dem Kursziel 3$ zu.Überschrift: BioLineRx in partnership with Novartis and collaboration with Roche
(Vom Mitglied beendet)
Stopped prediction by stratec for BioLine RX Ltd ADR
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€142.07
02.12.18
02.12.18
€45.00
12.05.20
12.05.20
-98.91%
12.05.20
12.05.20